Selected article for: "acute phase and inflammatory response acute phase"
Author: Zaid, Ikram; Essaad, Ounci; El aidouni, Ghizlane; Aabdi, Mohammed; Berrichi, Samia; Taouihar, Salma; Marbouh, Manal; Bkiyer, Houssam; Abda, Naima; Housni, Brahim
Title: Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: Cases series
  • Cord-id: 83ybtmjp
  • Document date: 2021_10_7
    • ID: 83ybtmjp
    Snippet: INTRODUCTION: COVID 19 pneumonia can lead to an inappropriate inflammatory response, and can be complicated by acute respiratory distress syndrome, multivisceral failure with a high mortality rate. OBJECTIVE: To observe the effect of therapeutic plasma exchange on the excessive inflammatory response. MATERIALS AND METHODS: In this study, we included 7 confirmed cases of COVID-19 in the intensive care unit (ICU) department of the university hospital of Oujda. COVID-19 cases were confirmed by RT P
    Document: INTRODUCTION: COVID 19 pneumonia can lead to an inappropriate inflammatory response, and can be complicated by acute respiratory distress syndrome, multivisceral failure with a high mortality rate. OBJECTIVE: To observe the effect of therapeutic plasma exchange on the excessive inflammatory response. MATERIALS AND METHODS: In this study, we included 7 confirmed cases of COVID-19 in the intensive care unit (ICU) department of the university hospital of Oujda. COVID-19 cases were confirmed by RT PCR (reverse transcription‐polymerase chain) and CT (computerized tomography) imaging according to WHO guidelines. Therapeutic plasma exchange was performed decrease cytokine storm-induced ARDS (Acute respiratory distress syndrome). Inflammation marker assays were performed before and after therapeutic plasma exchange to assess its efficacy. RESULTS: Levels of inflammatory cytokines (IL-6) and acute phase response proteins, including ferritin and CRP, were elevated before therapeutic plasma exchange. After therapeutic plasma exchange, levels of acute phase reactants, inflammatory mediators, were significantly reduced (p < 0.05). CONCLUSION: Our data suggest that therapeutic plasma exchange reduces the inflammatory response in patients with severe COVID-19 not undergoing mechanical ventilation. Further studies are needed to explore the efficacy of therapeutic plasma exchange in patients with COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute onset and lung edema: 1, 2, 3, 4, 5
    • acute onset and lymphocyte number: 1
    • acute phase and adjunctive treatment: 1, 2
    • acute phase and liver enzyme: 1, 2
    • acute phase and lung edema: 1, 2, 3
    • acute phase and lymphocyte number: 1
    • acute phase protein and adjunctive treatment: 1
    • acute phase protein and liver enzyme: 1
    • acute phase protein and lung edema: 1
    • acute phase protein and lymphocyte number: 1
    • acute respiratory distress syndrome and adjunctive treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and liver enzyme: 1, 2, 3, 4, 5, 6
    • acute respiratory distress syndrome and lung edema: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lymphocyte number: 1, 2
    • liver enzyme and lymphocyte number: 1